the day 100 score predicts moderate to severe GVHD transplant mortality and survival after hematopoietic cell transplantation

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

The aim of this study was to develop a predictive score for moderate-severe chronic graft-versus-host disease (cGVHD) on day +100 after allogeneic stem cell transplantation (HSCT). We studied 1292 patients allografted between 1990 and 2016, alive on day +100 after transplant, without cGVHD, and with full biochemistry laboratory values available. Patients were randomly assigned to a training and a validation cohort (ratio 1:1). In the training cohort, a multivariate analysis identified 4 independent predictors of moderate-severe cGVHD: gamma-glutamyl transferase ≥75 UI/l, creatinine ≥1 mg/dl, cholinesterase ≤4576 UI/l, and albumin ≤4 g/dl. A score of 1 was assigned to each variable, producing a low (0 to 1), intermediate (2 to 3), and high (4) score. The cumulative incidence of moderate-severe cGVHD was 12%, 20%, and 52% (P < .0001) in the training cohort, and 13%, 24%, and 33% (P = .002) in the validation cohort, respectively. The 5-year cumulative incidence of transplant-related mortality (TRM) was 5%, 14%, 27% (P < .0001) and 5%, 16%, 31% (P < .0001), respectively. The 5-year survival was 64%, 57%, 54% (P = .009) and 70%, 59%, 42% (P = .0008) in the 2 cohorts, respectively. In conclusion, Day100 score predicts cGVHD, TRM, and survival and, if validated in a separate group of patients, could be considered for trials of preemptive therapy.
Lingua originaleEnglish
pagine (da-a)2309-2318
Numero di pagine10
RivistaBLOOD ADVANCES
Stato di pubblicazionePubblicato - 2022

Keywords

  • the day 100 score predicts moderate to severe GVHD transplant mortality and survival after hematopoietic cell transplantation

Fingerprint

Entra nei temi di ricerca di 'the day 100 score predicts moderate to severe GVHD transplant mortality and survival after hematopoietic cell transplantation'. Insieme formano una fingerprint unica.

Cita questo